| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |